Boehringer Ingelheim has launched a 100ml bottle size for Semintra to help facilitate long-term compliance and convenience for owners of cats with chronic kidney disease (CKD).Boehringer Ingelheim has launched a 100ml bottle size for Semintra to help facilitate long-term compliance and convenience for owners of cats with chronic kidney disease (CKD).

The new bottle size will last approximately 100 days when treating an average sized cat of 4 kg. 

Amy Scott, brand manager for Semintra said: "The new 100 ml bottle size will ensure that Semintra is even more convenient for owners, whilst facilitating long-term compliance that fits in well with recommended recheck intervals for CKD."

Cats with CKD have an overactive renin-angiotensin-aldosterone system (RAAS), which can lead to proteinuria and further progression of kidney disease. Semintra contains the active ingredient telmisartan – the only angiotensin receptor blocker (ARB) licensed for use in veterinary medicine. Boehringer says it provides targeted, long-lasting suppression of the RAAS1.

Semintra is a once daily oral liquid. Now available in both 30 ml and 100 ml bottle sizes, it has a six month shelf life after opening.

For further information on Semintra visit www.boehringer-academy.co.uk or contact your local Boehringer Ingelheim territory manager.

Reference

  1. Sent, U. et al. (2015) Comparison of efficacy of long-term oral treatment with telmisartan and benazepril in cats with chronic kidney disease. J Vet Intern Med. 29(6),1479-1487

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.